ClotHound: Restore Flow, Save Lives-Every Time
ClotHound: Restore Flow, Save Lives-Every Time ClotHound: Restore Flow, Save Lives-Every Time ClotHound: Restore Flow, Save Lives-Every TimeRetrieve, Restore, Revive

Retrieve, Restore, Revive
Retriever Medical is raising $15M to revolutionize venous thromboembolism (VTE) treatment, targeting blood clots in legs (DVT) and lungs (PE). Funds will drive technology development, clinical trials, and market expansion. Join us to transform patient care.
In a preclinical porcine thrombectomy model, ClotHound achieved 96% removal of chronic, wall-adherent thrombus with zero distal emboli.
Its dual-sphere independent design captured and extracted organized thrombus while maintaining complete embolic protection — confirming superior control and safety compared to legacy systems.
ClotHound PE redefines pulmonary embolism treatment with advanced mechanical thrombectomy featuring Active Controlled Expansion (ACE) and top-tier aspiration catheters. Designed to effectively remove thrombus and emboli from vascular structures, this innovative system delivers exceptional precision and efficiency. Thrombectomy reaches a new standard with cutting-edge technology—enhancing patient care with proven innovation. Explore the future of vascular care today!
ClotHound DVT transforms deep vein thrombosis treatment with advanced mechanical thrombectomy featuring Active Controlled Expansion (ACE) paired with top-tier aspiration catheters. Engineered to effectively remove thrombus and emboli from vascular structures, it offers exceptional accuracy and efficiency. Fast, innovative, and impactful, this breakthrough enhances DVT care for patients and clinicians alike!
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.